MiniMed Appoints Dr. David Segal as Chief Medical Officer
PR Newswire•03/11/2026•09:20 ET
1
Key Highlights
- ➤MiniMed (MMED) appoints David Segal, M.D., as Chief Medical Officer
- ➤Robert Vigersky becomes Chief Medical Officer Emeritus before planned 2027 retirement
- ➤David Segal brings over 20 years of diabetes care and digital health experience
- ➤MiniMed says Segal will support clinical outcomes and its innovation pipeline
Expert Statements
Que Dallara, Chief Executive Officer of MiniMed
“Dr. Segal brings deep clinical expertise and a passion for using technology to improve diabetes care. His experience and perspective will be invaluable as we continue delivering strong clinical outcomes with our technologies and advancing our innovation pipeline. We're excited to welcome him to MiniMed and grateful for the strong foundation Dr. Vigersky has established.”
David Segal, Chief Medical Officer of MiniMed
“I've spent much of my career looking at how we can use technology and data to make diabetes care more proactive, personalized and accessible. What excites me about MiniMed is the opportunity to bring that thinking into the development of technologies that can reduce the daily burden of managing diabetes and help more people achieve better outcomes.”
MiniMed Appoints Dr. David Segal as Chief Medical Officer PR Newswire
NORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the appointment of David Segal, M.D., as Chief Medical Officer. Dr. Segal succeeds Robert Vigersky, M.D., who will transition to the role of Chief Medical Officer Emeritus ahead of his planned retirement at the end of 2027.
Get started
Create a free account to read the full story.